Professional background

Graduated from University of Aberdeen (1995), underwent training in Medical Ocology (1998 - 2007), with PhD undertaken at Cancer Research UK (2000 - 2004). Underwent training in cellular pathology (2007 - 2014), with Clinical Lecturer at Imperial College London (2008 - 2013) and Soft Tissue Sarcoma Fellowship at Royal Marsden Hospital (2013 - 2014).

Consultant pathologist at St George’s Hospital (2014 - 2023), specialising in GI, breast and cytopathology. Consultant pathologist at UCLH since 2023, specialising in GI pathology.

Research interests

  • GI Pathology

Languages spoken



  • PS Macklin, N Pillay, JL Lee, H Pitman, SScott, J Wang, C Craig, JL Jones, KA Oien, R Colling, SE Coupland, C Verrill on behalf of the CM-Path Molecular Diagnostics working group. CM-Path Molecular Diagnostics Forum - consensus statement on the development and implementation of molecular diagnostic tests in the United Kingdom. Br J Cancer. 2019:
  • J Wang, G Gerrard, K Dawson, L Foroni, M El-Bahrawy. Targeted Next Generation Sequencing of Solid Pseudopapillary Tumors of the Pancreas Shows Mutations in Genes Involved in the Wnt Signalling Pathway. Pathol Intl. 2019: 10.1111/pin.12778.
  • C Shah, J Wang, C Fisher, T Mubako, D Gonzalez, K Thway. Surgical pathology cut up and reporting of soft tissue tumors at a specialist center: retrospective evaluation of compliance with the UK Royal College of Pathologists soft tissue sarcoma dataset. How should we improve for the molecular age? J Clin Pathol, 2016; 69(9): 761-766.
  • J Wang, M El-Bahrawy. Expression profile of mucins (MUC1, MUC2, MUC5AC and MUC6) in ovarian mucinous tumors: changes in expressions from benign to malignant tumors. Histopathology. 2015; 66(4): 529-35.